Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolin Walter

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|December 5, 2022
The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patientsRabea Wagener, Carolin Walter, Franziska Auer, et al.
Biochimica Et Biophysica Acta|October 1, 2013
LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4Karina Häbig, Sandra Gellhaar, Birgit Heim, et al.
Frontiers in Pediatrics|February 24, 2023
Resolving inherited and <i>de novo</i> germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignanciesTriantafyllia Brozou, Layal Yasin, Danielle Brandes, et al.
Neuropharmacology|May 3, 2016
Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitroCarolin Walter, Laura E Clemens, Amelie J Müller, et al.
Neuropharmacology|October 18, 2019
Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HDElisabeth Singer, Carolin Walter, Doriano Fabbro, et al.
Journal of Pediatric Hematology/Oncology|May 10, 2022
Noncancer-related Secondary Findings in a Cohort of 231 Children With Cancer and Their ParentsRabea Wagener, Carolin Walter, Harald M Surowy, et al.
Oncogenesis|July 5, 2023
The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in miceMelanie Schoof, Gefion Dorothea Epplen, Carolin Walter, et al.
Scientific Reports|December 6, 2017
Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington diseaseElisabeth Singer, Carolin Walter, Jonasz J Weber, et al.
Nature Communications|May 9, 2025
Microvascular immunity is organ-specific and remodeled after kidney injury in miceRebecca Rixen, Paula Schütz, Carolin Walter, et al.
Brain, Behavior, and Immunity|November 2, 2022
Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjectsVinicius Daguano Gastaldi, Justus Bh Wilke, Cosima A Weidinger, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|December 5, 2022
The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patientsRabea Wagener, Carolin Walter, Franziska Auer, et al.
Biochimica Et Biophysica Acta|October 1, 2013
LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4Karina Häbig, Sandra Gellhaar, Birgit Heim, et al.
Frontiers in Pediatrics|February 24, 2023
Resolving inherited and <i>de novo</i> germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignanciesTriantafyllia Brozou, Layal Yasin, Danielle Brandes, et al.
Neuropharmacology|May 3, 2016
Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitroCarolin Walter, Laura E Clemens, Amelie J Müller, et al.
Neuropharmacology|October 18, 2019
Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HDElisabeth Singer, Carolin Walter, Doriano Fabbro, et al.
Journal of Pediatric Hematology/Oncology|May 10, 2022
Noncancer-related Secondary Findings in a Cohort of 231 Children With Cancer and Their ParentsRabea Wagener, Carolin Walter, Harald M Surowy, et al.
Oncogenesis|July 5, 2023
The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in miceMelanie Schoof, Gefion Dorothea Epplen, Carolin Walter, et al.
Scientific Reports|December 6, 2017
Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington diseaseElisabeth Singer, Carolin Walter, Jonasz J Weber, et al.
Nature Communications|May 9, 2025
Microvascular immunity is organ-specific and remodeled after kidney injury in miceRebecca Rixen, Paula Schütz, Carolin Walter, et al.
Brain, Behavior, and Immunity|November 2, 2022
Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjectsVinicius Daguano Gastaldi, Justus Bh Wilke, Cosima A Weidinger, et al.
Pageof 5